Actively Recruiting
Giant Cell Arteritis - Ways to Precision Medicine
Led by Wuerzburg University Hospital · Updated on 2025-12-22
400
Participants Needed
1
Research Sites
402 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
CONDITIONS
Official Title
Giant Cell Arteritis - Ways to Precision Medicine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater or similar to 18 years
- Primary diagnosis of giant cell arteritis or polymyalgia rheumatica
You will not qualify if you...
- Age under 18 years
- Lack of capacity to consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universitätsklinikum Würzburg
Würzburg, Germany
Actively Recruiting
Research Team
M
Michael Gernert
CONTACT
H
Hannah Labinsky
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here